Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 16;21(6):160-164.
doi: 10.1097/CLD.0000000000000035. eCollection 2023 Jun.

Brief overview of immunosuppression and its side effects after liver transplantation

Affiliations

Brief overview of immunosuppression and its side effects after liver transplantation

Anahita Rabiee et al. Clin Liver Dis (Hoboken). .

Abstract

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts to report.

Figures

None
Graphical abstract
FIGURE 1
FIGURE 1
A sample renal-sparing medication regimen after liver transplant.

References

    1. Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation. 2004;77(suppl 9):S44–51. - PubMed
    1. Charlton M, Levitsky J, Aqel B, O'Grady J, Hemibach J, Rinella M, et al. . International Liver Transplantation Society Consensus Statement on immunosuppression in liver transplant recipients. Transplantation. 2018;102:727–43. - PubMed
    1. Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. 2006;2006:Cd005161. - PMC - PubMed
    1. Lange NW, Salerno DM, Jennings DL, Choe J, Hedvat J, Kovac D, et al. . Nirmatrelvir/ritonavir use: managing clinically significant drug-drug interactions with transplant immunosuppressants. Am J Transplant. 2022;22:1925–6. - PubMed
    1. Moini M. Review on immunosuppression in liver transplantation. World J Hepatol. 2015;7:1355–68. - PMC - PubMed